Chongqing Zhifei Biological Products Balance Sheet Health
Financial Health criteria checks 6/6
Chongqing Zhifei Biological Products has a total shareholder equity of CN¥32.7B and total debt of CN¥5.0B, which brings its debt-to-equity ratio to 15.2%. Its total assets and total liabilities are CN¥53.6B and CN¥20.9B respectively. Chongqing Zhifei Biological Products's EBIT is CN¥8.5B making its interest coverage ratio -34925.2. It has cash and short-term investments of CN¥3.0B.
Key information
15.2%
Debt to equity ratio
CN¥4.96b
Debt
Interest coverage ratio | -34925.2x |
Cash | CN¥2.97b |
Equity | CN¥32.66b |
Total liabilities | CN¥20.91b |
Total assets | CN¥53.57b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300122's short term assets (CN¥45.7B) exceed its short term liabilities (CN¥20.2B).
Long Term Liabilities: 300122's short term assets (CN¥45.7B) exceed its long term liabilities (CN¥693.1M).
Debt to Equity History and Analysis
Debt Level: 300122's net debt to equity ratio (6.1%) is considered satisfactory.
Reducing Debt: 300122's debt to equity ratio has reduced from 31.7% to 15.2% over the past 5 years.
Debt Coverage: 300122's debt is well covered by operating cash flow (116.2%).
Interest Coverage: 300122 earns more interest than it pays, so coverage of interest payments is not a concern.